Introduction & Objectives: Bladder cancer (BC) is the 3rd most common urological malignancy in Australia, where Aboriginal and Torres Strait Islander (ATSI) people have more modifiable risk factors, earlier diagnosis and worse survival rates. This scoping review is the first to comprehensively map knowledge on this topic. Methods: A systematic search of MEDLINE, EMBASE, CINAHL, Web of Science, and grey literature sources was conducted. Abstracts and full-texts were reviewed, and references of all included sources were screened for additional sources. Two reviewers performed screening and data extraction. Results: Out of 1045 sources screened, 208 underwent full-text review, and 23 met inclusion criteria. Most sources were peer-reviewed journal articles (65%), while 87% reported cancer registry data. Only one source focused on patient outcomes from a single institution. Muscle invasive BC was the primary focus, with 1 source discussing non-muscle invasive disease. Treatments specifics were explored in only 2 sources. Most sources did not consider the social determinants of health (SDH) for ATSI Australian’s. When discussed, these included cultural beliefs (n=4), health education (n=1), geographic barriers (n=4), risk behaviors (n=3), and social cohesion (n=1), usually in the context of all cancers rather than BC specifically. Conclusions: The literature on bladder cancer in ATSI Australian’s is limited, particularly regarding non-invasive BC, treatment efficacy, and the impact of the SDH. Future studies should focus on individual institution experiences, the prevalence of superficial BC, and the lived experience of ATSI Australian’s to better understand how to reduce risk factors and improve survival.